Celldex (CLDX) volatility up into conference call to announce EMERGE results

Celldex (Nasdaq: CLDX) is hosting a conference call at 4:30 P.M. Eastern to announce topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer on May 23. June call option implied volatility is at 167, July is at 124, August is at 115, above its 26-week average of 88, according to Track Data.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Williams-Sonoma (WSM) call put ratio 1 call to 1.1 puts into quarter results
• Okta, Inc. (OKTA) call put ratio 1 call to 1 put into quarter results
• Nutanix (NTNX) call put ratio 3.9 calls to 1 put into quarter results